These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23037727)

  • 1. [Molecular pathophysiology and diagnosis of acute myeloid leukemia].
    Asou N
    Rinsho Ketsueki; 2012 Oct; 53(10):1549-59. PubMed ID: 23037727
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of acute myeloid leukemia.
    Döhner K; Döhner H
    Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O; Licht JD; Tallman MS
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute myeloid leukemia: from risk-adapted to genotype-specific therapy].
    Kayser S; Schlenk RF
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1577-80. PubMed ID: 21809245
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?
    Al-Kali A; Cherry M; Kimmell K; Holter J; Kern W; Gehrs B; Ozer H; Selby G
    Cancer Genet Cytogenet; 2010 Dec; 203(2):348-51. PubMed ID: 21156258
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities.
    Vicente C; Vazquez I; Conchillo A; García-Sánchez MA; Marcotegui N; Fuster O; González M; Calasanz MJ; Lahortiga I; Odero MD
    Leukemia; 2012 Mar; 26(3):550-4. PubMed ID: 21904383
    [No Abstract]   [Full Text] [Related]  

  • 8. Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation.
    Nanri T; Matsuno N; Kawakita T; Mitsuya H; Asou N
    Leukemia; 2005 Sep; 19(9):1673-5. PubMed ID: 16049512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostics and therapy of acute myeloid leukemia].
    Kern W; Haferlach T; Schoch C; Hiddemann W
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2208-13. PubMed ID: 12397550
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis of acute myeloid leukemia].
    Yasuda T; Naoe T
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():379-83. PubMed ID: 23133986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic factors of acute myeloid leukemia].
    Inokuchi K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and management of core-binding factor leukemias.
    Seiter K
    Curr Hematol Rep; 2003 Jan; 2(1):78-85. PubMed ID: 12901158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
    Ghanem H; Tank N; Tabbara IA
    Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.
    Grimwade D; Mrózek K
    Hematol Oncol Clin North Am; 2011 Dec; 25(6):1135-61, vii. PubMed ID: 22093581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemias with recurrent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy.
    Doubek M; Brychtova Y; Berkovcova J; Krejci M; Palasek I; Dvorakova D; Mayer J
    Leukemia; 2005 May; 19(5):885-8. PubMed ID: 15744338
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytogenetics of pediatric acute myeloid leukemia.
    Manola KN
    Eur J Haematol; 2009 Nov; 83(5):391-405. PubMed ID: 19563518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of leukemia using microarray technology].
    Kohlmann A; Schoch C; Schnittger S; Kern W; Haferlach T
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2216-22. PubMed ID: 12397553
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review.
    Marchesi F; Annibali O; Cerchiara E; Tirindelli MC; Avvisati G
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):331-46. PubMed ID: 21123080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics in acute leukemia.
    Mrózek K; Heerema NA; Bloomfield CD
    Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.